ATE407151T1 - In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung - Google Patents

In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung

Info

Publication number
ATE407151T1
ATE407151T1 AT01961446T AT01961446T ATE407151T1 AT E407151 T1 ATE407151 T1 AT E407151T1 AT 01961446 T AT01961446 T AT 01961446T AT 01961446 T AT01961446 T AT 01961446T AT E407151 T1 ATE407151 T1 AT E407151T1
Authority
AT
Austria
Prior art keywords
glucan
water soluble
beta
production
cold water
Prior art date
Application number
AT01961446T
Other languages
English (en)
Inventor
Keith Morgan
Original Assignee
Granate Seed Ltd
Roxdale Foods Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927982&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE407151(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Granate Seed Ltd, Roxdale Foods Ltd filed Critical Granate Seed Ltd
Application granted granted Critical
Publication of ATE407151T1 publication Critical patent/ATE407151T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/10—Working-up residues from the starch extraction, e.g. potato peel or steeping water, including pressing water from the starch-extracted material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT01961446T 2000-07-03 2001-07-03 In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung ATE407151T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ50554500 2000-07-03

Publications (1)

Publication Number Publication Date
ATE407151T1 true ATE407151T1 (de) 2008-09-15

Family

ID=19927982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961446T ATE407151T1 (de) 2000-07-03 2001-07-03 In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung

Country Status (9)

Country Link
US (1) US20040023923A1 (de)
EP (1) EP1299424B1 (de)
JP (1) JP2004502794A (de)
AT (1) ATE407151T1 (de)
AU (2) AU8270801A (de)
CA (1) CA2413026C (de)
DE (1) DE60135658D1 (de)
ES (1) ES2313976T3 (de)
WO (1) WO2002002645A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005513140A (ja) * 2001-12-11 2005-05-12 セアプロ インク 穀類βグルカン組成物、その調製方法及び使用
EP1608236B1 (de) * 2003-04-02 2014-11-05 Cargill, Incorporated Verbesserte diätfaser, die niedermolekulares glucan umfassende materialien enthält
AU2004233913B2 (en) * 2003-05-02 2010-04-01 Ceapro Inc. Improved extration and purification method for cereal beta (1-3) beta (1-4) glucan
EP1638518B8 (de) * 2003-06-10 2012-11-21 Ceapro Inc. Orale zusammensetzungen auf der basis von beta glukan aus getreiden
PL1663266T3 (pl) * 2003-08-11 2013-07-31 Lesaffre & Cie Ściany komórkowe drożdży do leczenia lub zapobiegania hiperglikemii albo do stabilizacji glikemii
SE0401567D0 (sv) * 2004-06-17 2004-06-17 Biovelop Internat Bv Concentration of beta-glucans
WO2006002539A1 (en) * 2004-07-02 2006-01-12 The Governors Of The University Of Alberta AQUEOUS SOLUTIONS CONTAINING β-GLUCAN AND GUMS
CA2607004C (en) * 2005-05-05 2016-01-26 Sensient Flavors Inc. Production of beta-glucans and mannans
EP2155000A4 (de) * 2007-05-08 2013-12-25 Biothera Inc Teilchenförmig lösliches glucanpräparat
JP5528718B2 (ja) * 2008-03-31 2014-06-25 株式会社Ａｄｅｋａ βグルカン組成物を用いた血糖値上昇抑制剤及びインスリン分泌促進剤
US20090285970A1 (en) * 2008-04-11 2009-11-19 Thava Vasanthan Solubility-reduced, beta-glucan containing products and methods of producing and using such products
US20100015306A1 (en) * 2008-07-15 2010-01-21 Pepsico, Inc. Method for Preparing a Low Viscosity Whole Grain Flour Slurry
JP2010100576A (ja) * 2008-10-24 2010-05-06 Unitika Ltd 便秘改善剤
JP5506229B2 (ja) * 2009-04-09 2014-05-28 サッポロビール株式会社 メタボリックシンドローム改善又は予防剤
WO2011061144A2 (en) 2009-11-20 2011-05-26 Basf Se The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen
AU2013203451B8 (en) * 2010-11-29 2015-10-29 Biotec BetaGlucans AS Glucan Gels
GB201020190D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
GB201020191D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
JP2014505728A (ja) * 2011-02-17 2014-03-06 アボット・ラボラトリーズ 穀物性ベータグルカンおよび難消化性デンプンを含む水溶性栄養組成物
BE1020120A3 (nl) * 2011-06-06 2013-05-07 Duynie Holding Bv Samenstelling van voedsel voor dieren.
EP2700321A1 (de) 2012-08-24 2014-02-26 Etablissements J. Soufflet Wässrige Lebensmittelzusammensetzung angereichert mit Beta-Glucan
EP3028583A1 (de) 2014-11-17 2016-06-08 Etablissements J. Soufflet Flüssiges, mit B-Glucan angereichertes Milchgetränk
SE540993C2 (en) 2017-05-29 2019-02-26 Creal Food Ab A process for preparation of cereal fractions
SE542822C2 (en) 2018-11-29 2020-07-14 Creal Food Ab A process for preparation of cereal fractions
TWI840668B (zh) * 2021-05-13 2024-05-01 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療腸躁症之組成物之用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301848A (en) * 1962-10-30 1967-01-31 Pillsbury Co Polysaccharides and methods for production thereof
JPS5136359B1 (de) * 1968-10-14 1976-10-07
US4428967A (en) * 1979-06-12 1984-01-31 Research And Development Institute, Inc., At Montana State University Processes for production of waxy barley products
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
US5013561A (en) * 1984-08-10 1991-05-07 Barco, Inc. Process for recovery of products from waxy barley
US4804545A (en) * 1984-08-10 1989-02-14 Barco, Inc. Production of beta-glucan, bran, protein, oil and maltose syrup from waxy barley
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
US4996063A (en) * 1989-06-30 1991-02-26 The United States Of America, As Represented By The Secretary Of Agriculture Method for making a soluble dietary fiber composition from oats
US5458893A (en) * 1992-03-06 1995-10-17 The Quaker Oats Company Process for treating water-soluble dietary fiber with beta-glucanase
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5599697A (en) * 1992-12-14 1997-02-04 Takeda Chemical Industries, Ltd. Method of producing β-1,3-glucan
JP3532232B2 (ja) * 1992-12-14 2004-05-31 武田キリン食品株式会社 β−１，３−グルカンの新規製造法
CA2134138C (en) * 1994-01-24 1998-06-16 William E. Haast Lyophilized health food products and methods of making same
JPH07248297A (ja) * 1994-03-10 1995-09-26 Sapporo Breweries Ltd β−グルカンの測定法
US5512287A (en) * 1994-05-12 1996-04-30 Centennial Foods, Inc. Production of β-glucan and β-glucan product
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
WO1998013056A1 (en) * 1996-09-25 1998-04-02 Gracelinc Limited Beta-glucan products and extraction processes from cereals
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6143883A (en) * 1998-12-31 2000-11-07 Marlyn Nutraceuticals, Inc. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
US6083547A (en) * 1999-01-14 2000-07-04 Conagra, Inc. Method for obtaining a high beta-glucan barley fraction
WO2000056268A2 (en) * 1999-03-23 2000-09-28 New Zealand Institute For Crop & Food Research Limited Beta glucan extraction from cereals

Also Published As

Publication number Publication date
US20040023923A1 (en) 2004-02-05
AU2001282708B2 (en) 2007-01-04
AU2001282708C1 (en) 2002-01-14
ES2313976T3 (es) 2009-03-16
EP1299424B1 (de) 2008-09-03
CA2413026C (en) 2009-12-22
DE60135658D1 (de) 2008-10-16
JP2004502794A (ja) 2004-01-29
CA2413026A1 (en) 2002-01-10
AU8270801A (en) 2002-01-14
WO2002002645A1 (en) 2002-01-10
EP1299424A4 (de) 2004-09-01
EP1299424A1 (de) 2003-04-09
WO2002002645A8 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
ATE407151T1 (de) In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
NO980213L (no) Polysakkaridgel-blanding
UY26655A1 (es) Composiciones gelificadas y gelificables para productos alimenticios
NO955315L (no) Fremgangsmåte for fremstilling av vandige polymeremulsjoner
ATE312823T1 (de) Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
ATE400592T1 (de) Emulgatorfreies wässriges emulsionspolymerisationsverfahren zur herstellung von fluorpolymeren
DK1117304T3 (da) Hydrokolloid konfekturevare
TW502011B (en) Process for producing n-long-chain acyl acidic amino acids or salts thereof
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
ATE326499T1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
NO20015986D0 (no) Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan
WO2004096792A3 (fr) Nouveaux derives de l'indole, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de kdr
ATE402211T1 (de) Verfahren zur herstellung von farblosen, lagerstabilen biuretgruppenhaltigen polyisocyanaten
ATE193297T1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE509117T1 (de) Herstellungsverfahren für hyaluronsäure oder ihre derivate
ATE262529T1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DE69426495D1 (de) Weizensprossensaft enthaltendes stabiles präparat und verfahren zu seiner herstellung
JP2004196796A5 (de)
JPS5584504A (en) Coagulant
WO2003099870A3 (fr) Procedes d'obtention d'oligo-mannuronates et guluronates, les produits obtenus et leurs utilisations
JPS63245495A (ja) 両性界面活性剤の製造方法
KR950002768A (ko) 식용달팽이 혼합즙의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties